While its role in OA remains unclear, evidence from studies on colorectal cancer suggests that TSPAN8 modulates cell motility by linking epidermal growth factor receptor (EGFR) signaling to integrin/TLR-mediated pathways; EGFR silencing was found to enhance migration in TSPAN8-expressing cells [40]. Here, TSPAN8 is linked to colorectal cancer.